CLINICALLY ISOLATED SYNDROME, CNS DEMYELINATING

Clinical trials for CLINICALLY ISOLATED SYNDROME, CNS DEMYELINATING explained in plain language.

Never miss a new study

Get alerted when new CLINICALLY ISOLATED SYNDROME, CNS DEMYELINATING trials appear

Sign up with your email to follow new studies for CLINICALLY ISOLATED SYNDROME, CNS DEMYELINATING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Brain repair trial tests common allergy drug for MS

Disease control Not yet recruiting

This study is testing if an existing allergy medication, clemastine fumarate, can help repair the protective coating (myelin) around nerves in the brain for people with multiple sclerosis (MS). It will involve 44 adults with MS who have recently active brain lesions. Researchers …

Matched conditions: CLINICALLY ISOLATED SYNDROME, CNS DEMYELINATING

Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

CLINICALLY ISOLATED SYNDROME, CNS DEMYELINATING

Get alerted when new CLINICALLY ISOLATED SYNDROME, CNS DEMYELINATING trials appear

Brain repair trial tests common allergy drug for MS